Bioinvent Intern Stock Price, News & Analysis
Company Description
Bioinvent Intern (OTC Link: BOVNF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $216.4M.
BOVNF stock has declined 30.0% over the past year. Shares last traded at $3.29.
This page provides a comprehensive overview of BOVNF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bioinvent Intern (BOVNF) stock last traded at $3.29. Over the past 12 months, the stock has lost 30.0%. At a market capitalization of $216.4M, BOVNF is classified as a micro-cap stock with approximately 65.8M shares outstanding.
Latest News
Bioinvent Intern has 8 recent news articles. Key topics include clinical trial, conferences, earnings. View all BOVNF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bioinvent Intern (BOVNF) currently stands at 113 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Bioinvent Intern (BOVNF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BOVNF Company Profile & Sector Positioning
Bioinvent Intern (BOVNF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BOVNF often look at related companies in the same sector, including Silence Therapeutics Plc (SLNCF), Oryzon Genomics (ORYZF), Nervgen Pharma Corp (NGENF), Hansa Medical AB (HNSBF), and Adocia (ADOCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BOVNF's relative position within its industry.